JAK2 Mutation V617F Test
JAK2 Mutation (V617F) by RT-PCR Test
Direct answer: This test detects the JAK2 V617F gene mutation linked to blood-related bone marrow disorders.
The JAK2 Mutation (CPMD V617F) by RT-PCR test is a molecular genetics assay that identifies a specific change in the Janus Kinase 2 (JAK2) gene. This gene regulates blood cell production in the bone marrow. The V617F mutation causes uncontrolled cell growth and is commonly associated with myeloproliferative neoplasms, a group of blood disorders affecting red cells, white cells and platelets. Detection helps confirm diagnosis and guide specialist treatment planning.
This test is available at healthcare nt sickcare with home collection facility in Pune and direct walk-in sample submission at our Aundh centre. Samples are processed through NABL-accredited partner laboratories with secure digital reporting for patients across Pune, Maharashtra.
Who Should Consider This Test?
Direct answer: Individuals with unexplained high blood counts or suspected bone marrow disorders.
This test is commonly advised when routine blood reports show persistently high haemoglobin, platelets or white blood cells, or when doctors suspect polycythaemia vera, essential thrombocythaemia or myelofibrosis. Early genetic confirmation supports accurate diagnosis and long-term monitoring.
Patient Resources
Frequently Asked Questions
When should I do the JAK2 mutation test?
Why is this test advised?
Is fasting required before this test?
What symptoms may prompt this test?
Â
Original: $7,499.00
-70%$7,499.00
$2,249.70Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
JAK2 Mutation (V617F) by RT-PCR Test
Direct answer: This test detects the JAK2 V617F gene mutation linked to blood-related bone marrow disorders.
The JAK2 Mutation (CPMD V617F) by RT-PCR test is a molecular genetics assay that identifies a specific change in the Janus Kinase 2 (JAK2) gene. This gene regulates blood cell production in the bone marrow. The V617F mutation causes uncontrolled cell growth and is commonly associated with myeloproliferative neoplasms, a group of blood disorders affecting red cells, white cells and platelets. Detection helps confirm diagnosis and guide specialist treatment planning.
This test is available at healthcare nt sickcare with home collection facility in Pune and direct walk-in sample submission at our Aundh centre. Samples are processed through NABL-accredited partner laboratories with secure digital reporting for patients across Pune, Maharashtra.
Who Should Consider This Test?
Direct answer: Individuals with unexplained high blood counts or suspected bone marrow disorders.
This test is commonly advised when routine blood reports show persistently high haemoglobin, platelets or white blood cells, or when doctors suspect polycythaemia vera, essential thrombocythaemia or myelofibrosis. Early genetic confirmation supports accurate diagnosis and long-term monitoring.
Patient Resources
Frequently Asked Questions
When should I do the JAK2 mutation test?
Why is this test advised?
Is fasting required before this test?
What symptoms may prompt this test?
Â
